USA – Pfizer CEO, Albert Bourla has said that the company expects a Covid-19 vaccine targeting the Omicron variant to be ready in March. Albert Bourla told CNBC that the…
Read MoreOmicron vaccine to be ready in March, says Pfizer CEO
Tag: Albert Bourla
Pfizer scores another Paxlovid deal with the US government
USA – The United States has increased its order for Pfizer’s COVID-19 antiviral Paxlovid from 10 million to 20 million courses, the company has announced. With two COVID-fighting antiviral pills…
Read MoreInvestors push for pharma companies to broaden global access to COVID vaccines
USA – A group of institutional investors is urging companies to tie CEO pay to equitable access to the COVID vaccine. Pay packages for CEOs at COVID vaccine makers Pfizer,…
Read MorePfizer plans to ramp up antiviral pill production in fight against Omicron variant
USA – Pfizer CEO, Albert Bourla has confirmed the company’s plans to increase production of its Paxlovid antiviral treatment in order to combat the spread of the new Omicron variant.…
Read More